Predict your next investment

HEALTHCARE | Biotechnology
icosavax.com

See what CB Insights has to offer

Business Relationships

1

Icosavax Partners & Customers

1 Partners and customers

Icosavax has 1 strategic partners and customers. Icosavax recently partnered with University of Washington on April 4, 2021.

Date

Type

Business Partner

Country

News Snippet

Sources

4/7/2021

Licensor

University of Washington

United States

Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine Candidate Into Clinical Trials

For SARS-CoV-2 , Icosavax , Inc. has a worldwide license with an exclusive option for IVX-411 in North America and Europe from the University of Washington .

6

Date

4/7/2021

Type

Licensor

Business Partner

University of Washington

Country

United States

News Snippet

Icosavax Closes $100 Million Series B Financing to Advance Bivalent RSV/hMPV Vaccine Candidate Into Clinical Trials

For SARS-CoV-2 , Icosavax , Inc. has a worldwide license with an exclusive option for IVX-411 in North America and Europe from the University of Washington .

Sources

6

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.